Edition:
India

People: Carmat SA (ALCAR.PA)

ALCAR.PA on Paris Stock Exchange

19.54EUR
25 Sep 2020
Change (% chg)

€0.00 (+0.00%)
Prev Close
€19.54
Open
€19.54
Day's High
€19.60
Day's Low
€19.26
Volume
7,118
Avg. Vol
7,487
52-wk High
€22.95
52-wk Low
€10.10

Pouletty, Philippe 

Dr. Philippe Pouletty M.D. serves as Director - Representative of Truffle Capital of the Company. Dr. Philippe Pouletty is a pioneer in biotechnology and medical devices. He founded SangStat in 1988, a company specialising in organ transplant therapy, listed on the NASDAQ, then Conjuchem in 1993, a biotech firm specialised in developing next-gen medicines from therapeutic peptides, listed on the Toronto Stock Exchange. He is the co-founder and CEO of Truffle Capital, founder and Chairman of Deinove, a biotech company that develops compounds for industry from rare microorganisms, and Abivax, an innovative biotech firm that targets the immune system to eliminate viral and inflammatory diseases. Dr. Pouletty is also founder of Carbios, a green chemical company developing innovative enzyme processes to reshape the lifecycle of plastics, co-founder and board member of Pharnext, a leading biopharma company in combinatorial medicine, and Vexim, an innovative medical devices company, Chairman of Diaccurate, a biotech company specialising in immunomodulation, and board member at Myopowers, Biokinesis, Kephalios and all other companies in the Truffle Capital portfolio.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --